Spread the love

Speaking of an aging population that reaches a tipping point in 2015 never before seen in the history of civilization, Alzheimer’s will be a significant global medical issue.   Researchers at the Stanford University School of Medicine led by Katrin Andreasson, MD, have been able to counter the effects of Alzheimer’s in mice. Results demonstrated that blocking a single protein receptor (EP2) in mice resulted in a huge reduction in inflammatory activity in the brain. Blocking the protein allows microglia to function normally again so they are able to rid cells of amyloid-beta plaques which build up on and damage nerve cells in Alzheimer’s disease. The study was published on Dec. 8 in The Journal of Clinical Investigation. It also may help to explain why it appears taking aspirin before onset may reduce the rate of the disease. The study was supported by:

For the latest research in the field, follow the 12th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders taking place on March 18 – 25, 2015 in Nice France. Photo: PBS.org